RT Journal Article
T1 Topical mesalazine as a cause of Stevens-Johnson syndrome.
A1 Núñez Ortiz, Andrea
A1 Trigo Salado, Claudio
A1 de la Cruz Ramírez, María Dolores
A1 Herrera Justiniano, José Manuel
A1 Leo Carnerero, Eduardo
AB Mesalazine is a drug routinely used in ulcerative colitis and usually has few side effects. There have been reports of uncommon cases of severe mucocutaneous damage, such as Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN), induced by salicylates. It is important to diagnose these promptly due to the high morbidity and mortality rates. We describe the case of a 46-year-old female with ulcerative proctitis, who developed SJS following topical mesalazine use. The lesions responded well to intravenous corticosteroids after discontinuation of the drug.
SN 1130-0108
YR 2018
FD 2018
LK http://hdl.handle.net/10668/12634
UL http://hdl.handle.net/10668/12634
LA en
DS RISalud
RD Apr 6, 2025